Array BioPharma Inc. (NASDAQ:ARRY): Up to Date Analyst Ratings
Array BioPharma Inc. (NASDAQ:ARRY) registered a -5.18% decrease, still its new closing price is 345.80% up from the company’s 1 year high of 11.65.It posted …
Array BioPharma Inc. (NASDAQ:ARRY) registered a -5.18% decrease, still its new closing price is 345.80% up from the company’s 1 year high of 11.65.It posted …
Array BioPharma Inc. (NASDAQ:ARRY) showed a growth of 1.27% from the market’s prior closing price. That gain sent the price at $11.19 per share as …
Array BioPharma Inc. (NASDAQ:ARRY) showed a growth of 0.09% from the market’s prior closing price. That gain sent the price at $11.25 per share as …